AAMC blog

LANDMARK LAWSUIT CHALLENGING THE CONSTITUTIONALITY OF THE CONTROLLED SUBSTANCES ACT

noreply@blogger.com (Arthur Livermore) — Wed, 26 Jul 2017 00:07:00 +0000

JEFF SESSIONS SUED IN LANDMARK LAWSUIT CHALLENGING THE CONSTITUTIONALITY OF THE CONTROLLED SUBSTANCES ACT
Beleaguered Attorney General Jeff Sessions was named a defendant today in a federal lawsuit challenging the constitutionality of the Controlled Substances Act as it pertains to Cannabis/Marijuana. In a 90-page Complaint, attorneys representing five plaintiffs maintain that the CSA, in classifying Cannabis as a Schedule I drug, is so irrational that it violates the U.S. Constitution.
In their Complaint, plaintiffs demonstrate that the Federal Government does not, and could not possibly, believe that Cannabis meets the definition of a Schedule I drug, which is reserved for the most dangerous of substances, such as heroin, LSD and mescaline. By way of comparison, cocaine and crystal meth are considered Schedule II drugs and are thus considered less addictive and less dangerous.
To be classified under Schedule I, a drug: (i) must have a high potential for abuse; (ii) must have absolutely no medical use in treatment; and (iii) cannot be used or tested safely, even under strict medical supervision. The plaintiffs point out that the Federal Government knows that Cannabis does not meet these requirements, especially given that, among other things, the Federal Government: (a) obtained its own medical patent based upon the Federal Government’s assertion that medical Cannabis is a safe and effective treatment for Alzheimer’s Disease, Parkinson’s Disease, and HIV-induced dementia (among other conditions); (b) established a national policy to refrain from investigating and/or prosecuting medical Cannabis businesses and users in the 29 States and three other areas under American jurisdiction (including Washington, DC) that have legalized Cannabis for medical and/or recreational use; (c) provided instructions, through issuance of the FinCen Guidance, on how financial institutions can bank Cannabis business; and (d) admitted that Cannabis does constitute medicine, including through statements by the U.S. Surgeon General and a Federal Administrative Law Judge.
“The record makes clear that the CSA doesn’t make any rational sense, and the Federal Government knows it,” says Michael Hiller, lead counsel in the case. Hiller went on to explain that, “if the Federal Government doesn’t believe in the rationality of its own statute, it’s unconstitutional to enforce it.”
Among the other claims in the lawsuit are that the CSA: (i) was enacted and implemented in order to discriminate against African Americans and to suppress people’s First Amendment rights; and (ii) violates plaintiffs’ constitutional Right to Travel.
The plaintiffs include:
* retired professional football player and Super Bowl Champion, Marvin Washington, who desires, but is ineligible (due to the CSA) to obtain grants under the Federal Minority Business Enterprise program, to open a business that would allow professional football players (among others) to treat with medical Cannabis to reduce opioid dependency and addition;
* an 11-year old girl, Alexis Bortell, who moved to Colorado from Texas so that she could treat her intractable epilepsy with medical Cannabis;
* a six-year old Georgia boy suffering from Leigh’s Disease, Jagger Cotte, who has been using medical Cannabis to lengthen his life and control his otherwise excruciating pain;
* disabled military combat veteran Jose Belen, who uses medical Cannabis to control his post-traumatic stress disorder (PTSD); and
* the Cannabis Cultural Association, whose membership includes many People of Color who contend that the CSA was enacted and has been enforced in a discriminatory manner, rendering them unable to participate in, among other things, the Cannabis industry.
Lauren Rudick, a member of Hiller’s firm representing Cannabis businesses, observed that, at present, “more than 60% of Americans live in a jurisdiction in which medical Cannabis is legal.” She also remarked that a “4/20/2017 Quinnipiac poll found that over 90% of Americans support the use of medical Cannabis and it’s near impossible to get 90% of the Country to agree on anything.” These numbers led Joseph Bondy, a federal criminal defense attorney and legalization advocate working as co-counsel with the Hiller firm on this case, to question the agenda of those who continue to push for enforcement of the CSA, given its unlawful and discriminatory impact and that so few in America support such an effort.
The defendants in the case are Attorney General Jeff Sessions, Acting Administrator of the DEA Chuck Rosenberg, the Justice Department, the DEA and the Federal Government. Co-counsel David Holland, a litigator and longtime advocate for legalization of Cannabis, noted that the the efforts to criminalize Cannabis are relatively recent and were largely underwritten by racial and ethnic animus. As reflected in the Complaint, African Americans and other persons of color are four times as likely to be arrested under the CSA than white Americans, even though Cannabis is used equally by People of Color and Caucasians.
Contact: Michael S. Hiller (212) 319-4000 x. 308 and (646) 408-5995
Lauren Rudick (212) 319-4000 x. 319 and (917) 405-4206
Joseph Bondy (646) 335-3988
David Holland (212) 842-2480 and (917) 861-2678

Dr Uma Uplifting Health and Wellness

noreply@blogger.com (Arthur Livermore) — Mon, 06 Jun 2016 16:53:00 +0000

The Highs and Lows of Bipolar Disorders

noreply@blogger.com (Arthur Livermore) — Mon, 31 Aug 2015 23:56:00 +0000

Source: TopCounselingSchools.org

Cannabis should be removed from the regulatory jurisdiction of the CSA

noreply@blogger.com (Arthur Livermore) — Tue, 02 Jun 2015 23:37:00 +0000

Here's Why We Should Rethink Rescheduling Marijuana By Jon Gettman ·

Fri May 29, 2015

Editor's Note: These remarks are a summary of a presentation by the author, Jon Gettman, to the Ninth National Clinical Conference on Cannabis Therapeutics.

After observing the final stages of NORML’s original effort to reschedule marijuana in the late 1980s and early 1990s and leading two successive efforts to use the rescheduling process to make marijuana available as medicine under the federal Controlled Substances Act during the last 20 years, I know as much about this regulatory framework as anyone.

Rescheduling cannabis under the Controlled Substances Act—based on the history of these three failed efforts—is clearly not a feasible option for changing federal law with respect to medical marijuana. Furthermore, it is no longer an acceptable policy option. Marijuana must be removed from the Controlled Substances Act (CSA).

This is not a matter of “descheduling,” as many have begun to describe it—as this term actually invokes the procedures of the CSA to remove a drug from its regulatory provisions. Instead, cannabis should be removed from the regulatory jurisdiction of the CSA and regulated by new laws modeled on federal regulations for alcohol and tobacco.

There are a lot of reasons for this. First, cannabis is not a drug. Opponents of medical marijuana deride the plant as a crude drug because of the number of cannabinoid chemical compounds it contains... As if this is a bad thing. Actually, this is one of the good things about cannabis; it is an elegant botanical compound.

The history of rescheduling demonstrates why marijuana does not belong in the schedules of the CSA. The NORML rescheduling effort took over two decades because of government opposition. The legal battle produced several court decisions that, in effect, forced the government to complete the statutory process for considering marijuana’s legal status under the CSA. This meant that the government had to formally assess whether marijuana has a high potential for abuse and whether or not it has an accepted medical use in the United States.

One key obstacle to rescheduling is that the federal courts provide the government with a great deal of discretion in making such determinations. As long as the explanation is reasonable and the process is neither arbitrary nor capricious, the government can do what it wants—as long as they can explain why they decided what they have decided.

In 1988, the original NORML petition went before an administrative law judge, Francis Young, who decided that the government’s decision to keep marijuana in Schedule I was indeed unreasonable, arbitrary and capricious. However, the DEA appealed his decision, and the courts eventually ruled in the agency's favor.

After the discovery of the endocannabinoid receptor system and subsequent research detailing why marijuana has a lower potential for abuse than other drugs (with the crucial support of HIGH TIMES), I filed a new rescheduling petition in 1995. This one was also rejected by the DEA, and the federal courts would not hear our appeal because I was not a medical marijuana patient—and thus was not personally affected by their decision.

In 2002, I organized the Coalition for Rescheduling Cannabis, consisting of several patients and medical marijuana advocacy organizations, and once again, with legal support from HIGH TIMES, filed the third rescheduling petition. This one was also rejected by the DEA, but the U.S. Court of Appeals agreed to hear our case. However, once again, the court ruled in the DEA’s favor for the same reason as before—the government has discretion to determine what constitutes accepted medical use in the United States.

It would have been nice to win one of these battles. But I had other objectives in mind as well.

The 1995 petition was filed before medical marijuana was legalized in California. At that time, one objective for the petition was to get a ruling that marijuana did not have a high abuse potential and did have medical value. While the petition failed, Proposition 215 achieved that in an influential and profound way. The other objective I had in mind was what in science we call falsification—to either make rescheduling work or to eliminate it as a viable policy option. I think the failure of the government to recognize modern science and adapt law to contemporary research eliminates rescheduling as a way to address the need for legal, regulated medical marijuana.

But let’s back up in time and look at two visionary prophets.

First, consider the sage advice of Lester Grinspoon, a pioneer in publicizing medical marijuana’s therapeutic value. Grinspoon’s long held opinion was, and is, that marijuana should be like aspirin, inexpensive and widely available. This should be the goal of public policy, and advocacy, today.

What is the purpose of the Controlled Substances Act? The purpose of the CSA is to produce a closed regulatory system. So, let’s consider an observation from the 1970s by a widely respected scholar about drug control systems. John Kaplan published a chapter in a book about drug control with a prescient observation. (The citation is contained in a recent article by this author and Michael Kennedy on modern cannabis regulation.) Kaplan observed that closed systems don’t work if you cannot effectively control the technology of production.

Prohibition has failed, and the country is moving toward marijuana’s legalization. This failure is due in large part to the government’s difficulty in controlling the technology of growing cannabis. The CSA is not a viable regulatory framework for medical cannabis because it is impossible to set up a closed system. It is just too easy to grow cannabis, anywhere in the United States.

Another problem is that the controls required by the CSA are more stringent than what currently exist in many states. America has already moved past the CSA paradigm, and it is time that the government, politicians and advocates recognize this.

The CSA and, for that matter, the regulatory process of the Food and Drug Administration is a sound piece of public policy. Both regulatory frameworks provide necessary protection for consumers with respect to safety and proving the effectiveness of pharmaceutical products. These frameworks also protect capital investment in research and development to produce pharmaceutical products. But they are inadequate and unnecessary with respect to the elegant botanical compound we call cannabis.

Regulatory law should not be used to inflate consumer costs—nor should the primary goal be to protect corporate profits or to guarantee tax revenue streams for the government. Indeed, inflated prices for marijuana serve to subsidize the current black market and exacerbate the very problems legalization seeks to resolve.

Rescheduling, at this point in time, is a cop-out.

It is an inadequate response to a pressing conflict between state and federal law. Marijuana should be removed from the schedules and regulated like alcohol and tobacco. The nation needs to heed the lessons of the past. As Kaplan observed, closed systems do not work when production cannot be controlled. More important, Lester Grinspoon was right. Marijuana should be like aspirin, inexpensive and widely available for therapeutic use.

Worldwide Campaign: Cannabis for Therapeutic Purposes is a Human Right

noreply@blogger.com (Arthur Livermore) — Mon, 23 Jun 2014 20:10:00 +0000

Patients Out of Time – An international consortium of medical cannabis organisations are demanding that humans, regardless of state or allegiance and without qualification, be able to use cannabis therapeutically. In a joint declaration, the organisations from Europe and North America refer to Article 3 of the Declaration of Human Rights adopted by the United Nations in 1948. The declaration is the beginning of a worldwide campaign on the use of cannabis for therapeutic purposes.

The declaration was published in six languages on a dedicated Web site (www.medical-cannabis-declaration.org), and it states: “Every medical doctor has the right to treat his or her patients with cannabinoids and cannabis products according to the rules of good medical care” and “every patient has the right to access cannabis and cannabinoids for medical treatment supervised by a medical doctor, regardless of social status, standard of living or financial means.”

“The declaration is based on overwhelming scientific evidence. It takes a strong stance against the prejudices and untruthfulness of lawmakers, other political players and ‘experts’ with limited medical knowledge on the issue,” says Franjo Grotenhermen, MD, Executive Director of the International Association for Cannabinoid Medicines (Germany).

It is the aim of the declaration to generate worldwide support and allow organizations around the globe to adopt a more definitive position. “The joint declaration and related Web site form the nucleus of a worldwide movement regarding the human right to use cannabis for therapeutic purposes,” adds Al Byrne of Patients Out of Time (USA). The declaration is the product of knowledgeable experts from multiple countries who are working to challenge anti-cannabis forces.

Cannabis has established medical use throughout the world’s history and, coupled with the recent discovery of the role of the endogenous cannabinoid system in the human body, must be made available to all citizens of all countries. The creators of the declaration designed it to encourage and allow both organizations and individuals to join them by signing the document in support of the common goal to create a worldwide campaign to end the wrongful prohibition of therapeutic cannabis. Many scientists, doctors and other experts in the field have already offered their support by adding their signatures.

To sign the Medical Cannabis Declaration click here

The initial signatories of the declaration are listed below. Please join us in demanding an end to medical cannabis prohibition and the inclusion of therapeutic cannabis in the national Pharmacopoeia of every country on earth:

American Cannabis Nurses Association (ACNA), USA
Americans for Safe Access (ASA), USA
Arbeitsgemeinschaft Cannabis als Medizin (ACM), Germany
Associazione per la Cannabis Terapeutica (ACT), Italy
International Association for Cannabinoid Medicines (IACM), International
Norsk Forening for Cannabinoidmedisin (NFCM), Norway
Patients Out of Time (POT), USA
Schweizer Arbeitsgruppe für Cannabinoide in der Medizin (SACM), Switzerland
Selbsthilfenetzwerk Cannabis Medizin (SCM), Germany
Society of Cannabis Clinicians (SCC), USA
Union Francophone pour les Cannabinoïdes en Médecine (UFCM), France and Luxembourg

Lester Grinspoon responds to David Brooks

noreply@blogger.com (Arthur Livermore) — Wed, 08 Jan 2014 23:55:00 +0000

The Harvard professor emeritus and author of Marihuana Reconsidered responds to the New York Times columnist’s anti-pot polemic.

Lester Grinspoon

Last week the New York Times columnist David Brooks wrote a piece, “Weed Been There, Done That,” which slammed the legalization of marijuana in Colorado and other states and labeled users stupid at worst and indolent at best. Among other criticisms, he wrote that cannabis is “not a particularly uplifting form of pleasure and should be discouraged more than encouraged.”

In making his case, Brooks cited long-debunked research and relied on old stereotypes that serious scholars discredited decades ago. One of the leading thinkers on the topic is Dr. Lester Grinspoon, Harvard psychiatrist and author of the 1971 classic, Marihuana Reconsidered, an exhaustive study of the scientific, medical, cultural and legal arguments against the plant. That book stripped away the myths, lies and distortions surrounding cannabis and sparked an enormous debate in this country and around the world. Joe Dolce spoke to the doctor, who at 85, from his home in Newton, Massachusetts.

Lester, how did you react to Brooks’ takedown of cannabis?
My overall impression is that David Brooks, who seems like a very smart man, is very much mistaken about what he thinks he knows about marijuana and out of date. I think he has just touched the tip of the iceberg in his experience with marijuana. His ignorance about this subject is vast. I hope he’s on more solid ground with the other things he writes about in the New York Times.

I was a psychiatrist at Harvard Medical School in the 1960s, and I saw all these people using this “dangerous drug.” I could see no problem that these people were having.

Let’s start at the top. He says that all of his friends gave it up after college, as if it’s indicative of some sort of emotional or psychological immaturity.
I think it’s true that most people who use it as young people do give it up in the course of their lives. I don’t think they give it up because it’s harmful. They give it up because they turn to other things, like getting married or having children, or having jobs with drug testing.

On the other hand, young people who use it and give it up don’t ever discover some of its other uses. It’s certainly a good recreational drug—better than alcohol or any other drug that might be considered recreational. It’s so…free. You don’t have a hangover, it’s less expensive in the long run, it doesn’t compromise functioning in a way that alcohol can.

But now it’s becoming increasingly understood that it is a very interesting and versatile medicine with much less toxicity than some of the pharmaceutical products it replaces. And more people at older ages are using it.

There’s a third category of use—and mind you these categories are conflated—which is the least appreciated: it’s what I call enhancement. Everyone knows that if you smoke, things that aren’t ordinarily culinary treats taste wonderful or that it can enhance a sexual experience. But I’m talking about experiences that aren’t so obvious. Like going to a museum. Take Allen Ginsberg’s experience with Cezanne….

He wrote about this in The Paris Review in 1965…
Ginsberg, who was a regular smoker of marijuana, was concerned that his friends were getting a great deal out of Cezanne but that he couldn’t really “see” his artistry. So he decided to smoke before going to the Museum of Modern Art to see Cezanne and he found an understanding that he had not been able to achieve sober. Furthermore, he pointed out that the perceptions stuck. It wasn’t something he saw only when high.

For many people that’s the case, and not just with art. My closest friend, Carl Sagan, used it as an adjunct or a catalyst for his creative processes. He wrote an essay for Marihuana Reconsidered under the pseudonym Mr. X, in which he described how he was in the shower one night with his wife, high on marijuana, and got the idea for 11 essays on the origins of racism along the lines of something called Gaussian distribution curves. He used these essays as the bases for university commencement addresses, lectures and in his books.

Carl Sagan and Lester Grinspoon, 1981

Brooks seems to say that smoking is a youthful folly, yet you didn’t start smoking until you were 43, correct?
I had a strange experience. I was a psychiatrist at Harvard Medical School in the 1960s, and I saw all these people using this “dangerous drug.” People would be smoking and I, as a physician, who knew everything about drugs—I was so arrogant I could have been the country’s drug czar—I would give them my little lecture on the dangers of marijuana and urge them to give it up.

Well, this went on for a while, even though I could see no problem that these people were having and they seemed to enjoy it a lot. And then I started to question what I knew about the scientific and medical basis of marijuana prohibition, and I went to the Conway Library to examine why we in this country were arresting about 300,000 people a year, 89% for possession, and most of them very young. [There are currently over 800,000 citizens in US jails for marijuana arrests. 24 million have been arrested for marijuana related offenses since the publication of Marihuana Reconsidered.]

And I had a very uncomfortable discovery—I had been brainwashed like just about every other citizen in this country. Marijuana was not a toxic drug. In fact it was remarkably nontoxic. The problem was not any inherent psychopharmalogical property with the drug itself, but rather the way we were treating it by arresting so many people, imprisoning some of them, and compromising their possibility for successful careers.

I published that paper in the International Journal of Psychiatry, and nobody read it. Well, almost nobody. One day I got a call from the editor of Scientific American who had seen the piece and asked me to condense it so he could publish it in his journal. It ran as the lead piece in November 1969. That created a big stir, and eventually Harvard University Press published Marihuana Reconsidered in 1971.

It wasn’t only that the data impressed me. I was becoming increasingly fascinated by what the drug had to offer. I resolved then that I must try some myself, but decided to postpone that adventure until after the book’s publication. If the book were successful, I thought I would undoubtedly be called before many legislative bodies and courts, which did occur. They might ask me if I had used it, and I didn’t want to compromise my objectivity. I finally decided in 1973 that I would start using it, and I’ve been using it ever since.

Marijuana is a thought generator. The mind shoots out many bad ideas and many good ideas. You’ve got to look at them straight to see if they hold up.

Brooks claims it’s addictive in 1 in 6 teenagers.
I don’t believe it is addictive, and there’s no evidence of it being so. You get addicted to things like alcohol, cigarettes or heroin and many opiate derivatives, but people do not become addicted to marijuana. There are people who use it all day long and that seems to me silly—you get the high in the morning but the rest of the day, there isn’t much. Nevertheless, it’s not an addiction because those people can give it up if they want to and will not suffer any withdrawal effects. Some may get a little irritable or depressed. That has nothing to do with withdrawal symptoms.

But addiction data is so deceptive. When some of these kids go through the criminal justice system, they often have to go into therapy. And the therapist, in order to get reimbursed, has to specify a reimbursable diagnosis and so he puts down cannabis addiction or dependence.

He claims that “smoking and driving is a good way to get killed.” Agree or disagree?
I am opposed to smoking and driving. Using any psychoactive drug, even one with a minor effect on reflexes is dangerous. However, unlike the stereotypical drunk driver who is speeding recklessly with one hand on the wheel and who isn’t in control of his car, the person who is high is usually in the right lane with both hands on the wheel and he’s going so slow he’s a pain in the neck. That doesn’t mean he hasn’t increased his risk—he might get distracted by a pretty scene on the road. However, I have to tell you there is far less danger to both the driver and other people from the stoned driver than the drunk driver.

People are seeing a relative or a friend using it medically and seeing results and asking, “Hey, what’s all the fuss about over this?”

He insists that young people who smoke “suffer IQ loss and perform worse on cognitive tests.”
Both of those statements are absolute nonsense. I’d like to see the data he finds convincing. I’ve been reading it for a long time now, and I find no data for either contention. A lot of those cognitive studies were compromised.

Let me give you a little anecdote. Years ago I got a call from the editor of a journal called Depression who asked me to give my feedback on an article on cannabis being useful in treating depression. I explored it and it seemed to be true. By the time the article was published, I noticed a new paragraph at the end that said we want the readers to know that while the studies say that marijuana is useful in treating depression, we in no way support its use for depression or any other purpose. And I said, “Why in the world did you add this last paragraph?” The editor almost started crying. She said, “Dr. Grinspoon, our lab is supported by NIDA [National Institute on Drug Abuse] and if we don’t include that we jeopardize our funding.” You’ve got to be careful with a lot of that literature. They won’t publish anything positive about marijuana.

He says there was one member of his clique who “may have been the smartest, but that there was something sad about him as he sunk deeper into pothead life…”
[Laughing] I would be careful about that type of comment. Carl Sagan and many smart people I know used pot and they weren’t sad people.

I like it both ways. I like it straight, and I like it stoned. I like to move from one state of consciousness to another.

He said it was “fun, but repetitive…Most of us figured out that weed doesn’t make you funny or more creative.”
I don’t know about making you funnier, but judging from my experience, it is a lubricant of creativity.

To Brooks’ mind, “Smoking weed was not something you were proud of or that people admire.”
That’s the cultural bias against marijuana. He’s supporting the enormous mistake that this country made in 1937 when it initiated the draconian prohibition on marijuana. Its use as a medicine is one of the reasons that the Gallup poll last year showed that 58% of Americans are now interested in getting rid of prohibition. That’s up 10% from a year ago! Support for rolling back prohibition is going up exponentially. [Ed. note: A CNN poll released on Jan. 6 showed that 55% of Americans support legalizing marijuana.] And the reason is that people are seeing a relative or a friend using it medically and seeing results and asking, “Hey, what’s all the fuss about over this?”

He writes, “I think we had a sense that the actions you take change you inside, making you a little less coherent….”
I disagree. Marijuana is a thought generator. The mind is always shooting out thoughts but with marijuana they shoot out in greater frequency. It shoots out many bad ideas and many good ideas. You’ve got to look at them straight to see if they hold up. But it generates ideas.

What do you say to this one: “Government should encourage higher pleasures like being in nature and should discourage lesser pleasures like being high.”
That may true for David Brooks, but it’s certainly not true for people like me. I like it both ways. I like it straight, and I like it stoned. I like to move from one state of consciousness to another. It’s a mild state of enhancement but it can help you to see around some corners that you haven’t been able to navigate before.

Tina Brown, former editor of The New Yorker and Vanity Fair tweeted this after Brooks’ column appeared: “Legal weed contributes to us being a fatter, dumber, sleepier nation, even less able to compete with the Chinese.” Will pot be our nation’s downfall?
I’ll tell you, I was delighted when Tina Brown was no longer editor of The New Yorker. I think this is emblematic of her point of view and that helps me understand why I never fond of her magazine. Pot has been around for at least 10,000 years, and the Chinese used it as a medicine as long ago as 5,000 years, so it’s likely that it grew somewhere near there and that wasn’t a lazy society. Fortunately it now grows all over the world.

noreply@blogger.com (Arthur Livermore) — Thu, 21 Nov 2013 20:41:00 +0000

Washington State Medical Cannabis Program Alternatives: A Whole Plant Botanical Cannabis Therapy Treatment Clinic Model

My name is Rick Rosio and I am a Washington State Citizen and an HIV Patient. I am also the program director of Washington’s Veterans for Compassionate Care, a program driven health care delivery clinic model that seeks approval to provide Whole Plant Botanical Cannabis therapy to the Warfighter communities.

The state has issued a new mandate in response to the passage of I-502 calling for all Washington Citizens who are medical patients using Cannabis as a therapy, to follow an entirely new framework for accessing Whole Plant Botanical Cannabis.

After careful review of the proposed amendments to the medical cannabis program of Washington State, we have concluded the proposed changes by the advisory group to the LCBD to merge the medical cannabis program into I-502 regulations is harmful and unacceptable to Washington Citizen/Patients.

We feel this move has the potential to deeply disadvantage the entire spectrum of the vulnerable disabilities communities.

This would effectively end the ability of Washington Citizen/Patients to have whole plant botanical cannabis substance access and make all other vulnerable patient loads exposed to new and unexpected regimes in finding the same type of palpable relief to many of the maladies that these patients have been unable to meet with traditional pharmaceuticals.

The cannabis benefit

The medical literature is full of historical evidence proving that Cannabis is indeed a very significant adjunct to wellness care, having been a “Traditional” substance offered in the medical pharmacopeia for many, many years before the unscientific ugly stain of Prohibition took it out.

It is this ideal of Wellness delivered through a whole plant botanical substance that is the Human Right of every Citizen within the Public Commons! The Cannabis Hemp Plant is a long standing member of the Public Commons, with ancient ties to human engagement for a myriad of uses. As such, it would be Anti-Human to keep the body politic itself out of the Public Commons, so why are we trying to keep a plant that has been a member of that same Public Commons longer than even we humans, when its benefits to humanity are so well enshrined throughout history.

We are Washington Citizens, therefore harken to our own cultural underpinnings of being “Pioneers”… hearty self-directed individuals hell-bent on bringing about a life worth living.

And that is the core of the message we want to bring today, that we are still “Pioneers” attempting to carry on our unique states’ mandate to craft lives worth living for each and every one of our Washington Citizens … for at some point, we will all be patients and deserving of the quality of experience that this spirit of what it means to be a Washington Citizen is all about.

Good compassionate care brought about in the most nurturing and hospitable form it can be delivered in – that is where and why Cannabis Therapy shines so bright, it has all those characteristics that make life worth living.

Affordable medicine

The Washington Medical Cannabis Program has produced a great number of benefits to our citizen/patients.

We have seen many of these vulnerable citizen/patient groups find relief in their increasing economic burdens brought about by an economic climate that has pushed many into situations where they can no longer afford any other option to being able to grow their own Whole Plant Botanical Cannabis and find uses for it that traditional medical treatments are simply not able to deliver.

Therefore, we cannot allow the complete eradication of the Medical Cannabis Program because of the unique abilities of the Cannabis Hemp Plant to meet the needs of our states most vulnerable. The sick and dying need special attention, those with life threatening conditions need specialized treatments, the economically depressed have special needs that only direct personal access to the plant can deliver.

There is a clear mandate for the state to regulate this segment and indeed bringing the benefits of the plant to the larger medical community is a valid long term strategy. The state feels a need to craft a regulatory environment to allow for the roll-out of the I-502 program, making a recreational component of this plant available by taking away the entirety of the existing Medical Cannabis Program.

One does NOT have to mean extinguishing the other.

The people voted for it … in 1998

The state can certainly produce a regulatory system to support a flourishing recreational model, while also crafting a similar regulatory scheme allowing for smart rational parameters that continue to allow for Washington Citizen/Patients who voted for the right to have Whole Plant Botanical Cannabis to continue on a redrawn blueprint for promoting wellness for our own states Citizen/Patients.

The citizens of this state have rights and now, one of them is to Whole Plant Botanical Cannabis and we urge our elected officials to recognize that we the Citizen/Patients have spoken clearly about this issue. The many benefits those that grow are able to achieve should not be totally taken away. The collective garden model is a necessary adjunct for those sick and injured who are not able to garden for themselves.

Now, with the state’s input at this crucial time, a new set of operating protocols can be established allowing for a more specified system that patients can use to guide them in pursuit of a self-directed healthcare regime.

What advances such a model is a regulatory system that affirms the Washington citizens’ rights to behavior consistent with the law of the state. This logically continues to provide for each citizen to care for themselves, with remade limits, either through a personal grow or a reworked collective garden model.

We’ll vote again …

The ideal of providing access point protection and regulation under Washington law is simply a smart and sensible control factor, one that could aid and assist during a transitional period to a full service commercial market place.

We vote, our friends and family members vote …

We will support the right of Washington State Citizen/Patients in keeping to the spirit of the existing medical cannabis program protocols while formulating new operating guidelines that enshrine these originating principles. We will campaign insuring that Washington will not return to a time of prohibitionist attitudes where the sick and suffering live in fear without personal access.

Motivations - Julia Glick

noreply@blogger.com (Arthur Livermore) — Fri, 27 Sep 2013 20:55:00 +0000

Day 14, September 27

Motivations

There are some, in the medical cannabis activist community who express to me that violating the law publicly in front of my previous employer is a mistake- that I am motivated by revenge, or that, since the laws governing cannabis are gradually relaxing, there is no need to push this issue into a more direct and confrontational place. I disagree completely with both assertions. This is my response.

The assertion that I am motivated by a desire for payback after my treatment as a nurse is nonsense on its face. Anyone who really knows me understands that revenge is an idea completely reprehensible to me on many levels. Revenge is based upon an unfulfilled feeling that a wrong has not been balanced through some application of justice- that the wronged party has a right to inflict pain on another person because that person inflicted pain on them. It is the law of the jungle, of the Old Testament, of many religions. I am not feeling that and I never have.

Let me be crystal clear: I am motivated for this action because of a much deeper level of appreciation- that even as the political framework creeps slowly towards some measure of justice for medical cannabis patients- the medical establishment of Oregon is stuck in a place which violates its ethics and responsibilities to treat ALL patients with acceptance and dignity and respect.

Let me get to the heart of the matter:

“Benzodiazepines and Marijuana

For different reasons, I advise against concurrent chronic opioids and either benzodiazepines or marijuana. Benzodiazepines and alcohol markedly increase the risk of overdose. The proliferation of state laws permitting medical and recreational use of marijuana make some physicians uncomfortable saying “No” to marijuana. Patients who request marijuana generally do so for “mood modulation.” It doesn’t make sense to me to add a drug to a pain regimen that has the analgesic properties of 50 mg of codeine when it already includes much more potent opioids. Patients should choose between marijuana and opioids, and I’m always surprised how many opt for the former.”

(Oregon Board of medical Examiners Newsletter, January 2013)

The BME newsletter from January 2013 articulates a position towards medical cannabis patients which is untenable on every level. It violates the ethics of medicine which REQUIRE clinicians to form trust relationships based on mutual consideration. It also violates the responsibility of medical systems to continually improve the delivery of health care based upon science and critical thinking.

It indicates a profoundly disturbing delusional process at the top level of Oregon medical practice that blames the victim of opiate addiction, even though it was the physician who made them addicted through over-prescribing of dangerous opiates.

If medical cannabis patients are going to be officially marginalized by the leadership of Oregon medical practice then I am going to speak about it. My lack of a license actually benefits me in that I can express myself without fear of Board of Nursing investigations. I believe I am more a nurse today than I have ever been.

If even one physician or nurse publicly supports this action I will be surprised. The medical board, with the support of the DEA, is an executioner standing forever above the head of any practicing physician who dares to question the utter insanity of this policy. I am not motivated by revenge towards Samaritan Health, but a belief that there are many good people in their system (including many physicians) who really believe that “patients come first”. And that the system is capable of improvement. Medical systems don’t get to pick and choose whom they respect. Treating 98% of patients with acceptance and dignity, while treating 2% with intolerance and rejection undermines the moral authority of the system.

The other criticisim I am hearing is that since the process of change is moving in the direction of increasing sanity why should I rock the boat? It might be perceived as crazy and outrageous by the population of the community.

To this I can only say that if standing up publicly to reject laws which are themselves baseless in actually protecting society is foolish, then I am foolish. If defending cannabis patients who are marginalized, drug tested, humiliated in office visits, subjected to pain contracts, forced to choose opiates or cannabis, rejected by their clinicians, or subjected to ignorant tirades by clinicians is foolish then I gratefully accept that title.

The medical establishment of Oregon is broken. The treatment of cannabis patients is unacceptable. I am giving an opportunity for the community of patients, or anyone rejected by the medical establishment- to voice their concern.

The process of change may be gradually occurring in the state of Oregon but it is not occurring in the offices of the Oregon BME. It is not happening in the Administration of Samaritan Health Services. I suspect that there will soon be new guidelines issued which require OMMP patients to choose either cannabis or opiates. Though reprehensible, perhaps it will be a good thing because tens-of- thousands of patients will stop using dangerous opiates. However forcing them with threats and pain contracts will further undermine trust, and subjecting patients to increasing pain for those who cannot rely on cannabis solely, is incomprehensible.

One additional comment: The much heralded process of change in these insane laws does not extend to the federal government or federal administrative level. Cannabis patients are utterly victimized by federal laws, and the change of administration and some funding increases will renew the war on patients. Also, the Dispensary Bill (HB 3460) passed into law this year, will likely be a mess of intruding agencies, fees, regulatory schemes, rules, taxes, surcharges, license fees, security systems, compliance systems, as every agency with some interest is lobbying to create some revenue stream for themselves. Even the OMMP itself is an over priced protection racket, extorting hundreds of dollars from patients in order to maybe keep the Oregon Sheriff from arresting them on some other charge. The price of cannabis in the dispensaries will sky rocket, and the black market will proliferate. That is my prediction.

Perhaps we are moving gradually in the right direction, but we have a long way to go. I intend to speed it up. I am doing my best to make change happen, and to act in a way which honors my life commitment to nursing. I am throwing this out to the community, and if what I am articulating is in fact real, the community of patients will respond. If it is fabricated then I will make a tiny impact, but I hardly doubt that this action will negatively reflect on the cannabis community unless I completely mess it up.

I take refuge in a belief that things can be a lot better, and that time for me to act is limited. I also take enormous strength from the people who I have tried to assist for these many years. I will assist them in every way I can, and frankly, I am mystified by the historical timidity of Oregon’s cannabis activist community. What I am planning is really pretty tame. We should be closing down the BME, we should be bringing business as usual to a halt, like my gay brothers and sisters did so well in response to the AIDS crisis many years ago.

Julia Glick

El Dorado County

noreply@blogger.com (Arthur Livermore) — Wed, 25 Sep 2013 19:51:00 +0000

Dave Bishop

It was a diverse group of people at the BOS in El Dorado county yesterday...there were people calling for complete bans because they had a personal demon or experience that, in their minds, demonstrated a need to ban cannabis at all levels...there was even a guy who insisted that there were dozens of pills that works just fine. And then he said, how his heart went out to those people that REALLY needed it, but then, it was back to, I don't believe it should be allowed. We had the drug free divide speak about the kids, but nobody suggested that someone, anyone, should teach their kids better, than to steal..

There were many people that spoke of the benefits of cannabis use and how these ordinances would surely cause them harm and suffering, then, at the end of the day, the supervisors passed two ordinances. The first allows the existing dispensaries to remain open, and the second effectively forces people that HAD been collectively cultivating, into those dispensaries. People will be allowed a 200 sq. ft. garden on properties of an acre to five acres, 400 for ten acres, and six hundred for twenty acres or more. BUT only THREE people may utilize any one parcel. This is a silly ass provision, as many people COULD collectively cultivate, within those guidelines.

Most of us went away feeling as though the board of supervisors, especially Mikulako, couldn't care less. It is frustrating to see the pain in the eyes of those this affects, and not want to scream out some sort of obscenity... This issue will be revisited in six months. Personally, I hope that when the smoke clears(no pun intended),that this outdoor grow ordinance doesn't create any issues for anybody...but I suspect, that El dorado county may have a number of actions taken against them, and whether or not those actions are successful , it will be an ugly time for our county, and a costly time. AND, since some things bare repeating, keep in mind, it is NOT my job to teach YOUR children what is right and what is wrong.

When those folks start parading the kids around saying they need to be kept safe from this plant, be reminded...honesty starts at home.it is not honesty to steal. If more people took their parental responsibility to heart...well you know.

Suit demands removal of cannabis from schedule I of the Controlled Substances Act.

noreply@blogger.com (Arthur Livermore) — Mon, 19 Aug 2013 19:12:00 +0000

8/17/13.

For immediate release.

I am Reverend Bryan Krumm, CNP. I am a Psychiatric Nurse Practitioner and I have filed a suit in the US District Court for New Mexico demanding removal of cannabis from schedule I of the Controlled Substances Act. 1:13-cv-00562-RB-LFG. The suit alleges the failure and the futility of the CSA's Administrative Process for scheduling, which is the responsibility of the Attorney General to enforce and which has been delegated to the DEA. These rules were enacted to ensure the safety of the American People.

Tragically, this legal process has been repeatedly violated by the Drug Enforcement Administration, which colludes with the Department of Health and Human Services, National Institutes of Health and National Institute on Drug Abuse in order to maintain the prohibition of Cannabis. Meanwhile, the Attorney General has ignored his responsibility to ensure the DEA acts fairly and legally. I have had a rescheduling petition filed with the DEA for over 3 years and the DEA has failed to respond to my argument, that because Cannabis now has "accepted medical use in the United States" by 20 States and the District of Columbia it is illegal to keep Cannabis in Schedule I. This failure of the administrative process has left me with no other choice than to seek extraordinary relief from the Courts.

In 1988, the DEA refused to remove Cannabis from schedule I of the CSA, in opposition to the recommendation of their own Administrative Law Judge. They cited a lack of "accepted medical use" as their rationale, in spite of overwhelming evidence of the safety and efficacy of Cannabis. There were no State Medical Cannabis Programs at that time. Cannabis now has "accepted medical use" in 20 States and the District of Columbia. The DEA simply looks the other way and continues to insist that "there is no accepted medical use in the United States". The DEA is violating the law by maintaining Schedule I placement of Cannabis in the CSA and in doing so, they have caused the deaths of hundreds of thousands of Americans.

The Defendants demand that more and better research be done while they actively block FDA approved research protocols looking for potential benefits of Cannabis. They claim that the thousands of studies in peer reviewed medical and scientific journals don't meet their level of scrutiny, while they engage in pseudoscience that is often never subjected to peer review. They simply ignore the large number of studies that have been conducted with smoked Cannabis in both the US and abroad, unless it is a study designed to find harm.

However, the issue at hand is not even about the research. It is about "accepted medical use". The quality of the research is clearly adequate for 20 States and the District of Columbia to have accepted the medical use of Cannabis. Therefore Cannabis does not meet the definition of a Schedule I drug which clearly states it can have "no" accepted medical use in the United States. Cannabis cannot legally remain in schedule I of the CSA if it has accepted medical use.

Cannabinoids, substances found in cannabis, activate specific receptors in the body called cannabinoid receptors. These receptors are involved in maintaining homeostasis and regulate many biological systems. Because of this, Cannabis has a broad range of therapeutic value. Because Cannabinoids have little effect on basic life support function, it is virtually impossible to overdose on Cannabis. There has never been a documented overdose death attributable solely to Cannabis. While mild changes in respiratory function can occur from smoking cannabis, we do not see the serious respiratory problems associated with tobacco use. Long term heavy use of cannabis has not been found to have a significant negative impact on overall health, and has been shown to provide significant relief from a great number of ailments.

In my clinical practice, Cannabis has proven to be the only medication consistently effective in treating PTSD. In the United States, 22 veterans suicide every day because there are no legal treatments which are consistently effective in treating PTSD. We have lost more active duty troops to suicide than to enemy fire in Iraq and Afganistan. Certainly the brave men and women who serve our country deserve better than to be denied a safe and effective treatment by appointed bureaucrats who are not held accountable to the American People.

Cannabis also has unique therapeutic value for treating cancer. In cancer, cannabinoids have been shown to induce apoptosis, the normal process of cell death which stops in cancer cells and leads to the development of tumors. Simply stated, cannabis may kill tumors while leaving health cells alone. Cannabis may also inhibit angiogenesis, the process by which tumors take over blood vessels to feed themselves, so cannabinoids starve the tumor. Finally, cannabinoids inhibit metastasis, the spread of the tumor to other areas of the body. Cannabis is far safer than any chemotherapeutic agent but Defendants refuse to allow human studies to be conducted so we can find out if cannabis might help save some of the over half a million Americans projected to die of cancer this year.

Alzheimer's is another disease for which we have no adequate treatments. Cannabis helps to prevent the deposition of amyloid plaques in Alzheimer's. It also shuts down the inflammatory processes which lead to neurodegeneration in Alzheimer's.

In my clinical practice, Cannabis has also proven to be effective in treating depression, anxiety, insomnia, nightmares, irritability, anger, psychosis, mood swings, pain, spasticity, cachexia, and even the core behavioral problems associated with profound Autism. It does so with superior safety and oftentimes greater efficacy than available pharmaceuticals. It is unreasonable, arbitrary and capricious for the DEA to stand between these sufferers and the medication they need to alleviate their symptoms.

As a Vet, I took an oath to defend the Constitution against all enemies, both foreign and domestic. By causing the death of hundreds of thousands of American Citizens, these agencies have proven that they have no respect for the Constitution or the Freedoms the Constitution is designed to protect. That is why I have brought this suit, to demand that these appointed bureaucrats are made to follow the law.

Rev. Bryan A Krumm CNP

Which State Has Had The Most Marijuana Reform During The 2013 Legislative Session?

noreply@blogger.com (Arthur Livermore) — Mon, 08 Jul 2013 23:14:00 +0000

With summer in full-swing, and with months of political bickering already behind us, the 2013 legislative session has adjourned for many states, with most of the remaining few finishing their final days. During this session, cannabis reform has been a popular and much-discussed topic in numerous states.

As a result, Colorado now has a regulation and taxation system in place for their newly-legal recreational cannabis industry, legislatures in Illinois and New Hampshire have approved measures legalizing medical cannabis, Vermont lawmakers voted to decriminalize small amounts of cannabis (which is already in effect), Nevada voted to legalize medical cannabis dispensaries, etc., etc..

With all of the movement made so far this year, one state stands out as having made the most progress in regards to their cannabis policies - the year obviously isn’t over, but we don’t see the outcome changing.

The state? Oregon.

Oregon’s Legislature – and governor – has taken multiple steps to drastically alter the state’s cannabis laws for the better, and activists continue to push for further reform.

Once each of the approved-proposals takes effect, these changes will be made to Oregon’s cannabis laws:

The possession of up to an ounce of cannabis will no longer be a misdemeanor charge – it will instead be a civil infraction (Senate Bill 40).
The possession of 1 to 4 ounces will be reduced from a felony, to a misdemeanor; even in states like Washington, where small amounts of recreational cannabis has been legalized, the possession of an ounce and a half or more remains a felony (Senate Bill 40).
The possession of up to an ounce will no longer result in the suspension of someone’s driver’s license – something that will effect over 5,000 people a year (Senate Bill 82).
Dispensaries will be explicitly legalized, finally providing patients in the state with a safe and (hopefully) consistent means to obtain their medicine. The measure which makes this change has been sent to the governor for final consideration; he’s expected to sign it into law (House Bill 3460).
Post traumatic stress disorder will be added as a qualifying medical cannabis condition (Senate Bill 281).

In addition to these changes, in April Oregon’s House Judiciary Committee become one of the first legislative committees in U.S. history to approve a measure which would explicitly legalize cannabis; the measure – which would have legalized possession, private cultivation and state-licensed retail outlets – has failed to advance, but has garnered a large amount of attention.

In response to the legislature’s refusal to act upon full legalization, the proponents of last year’s Measure 80 – which would have legalized cannabis in Oregon but failed narrowly in November’s general election - have filed two legalization initiatives (one a constitutional amendment, one a state-law change) aimed at the 2014 ballot.

All-in-all, it’s been a great year for cannabis law reform, especially in Oregon. We couldn’t be more excited to see the changes that will take place in the coming months and in the next legislative session!

Source: The Joint Blog

THC blocks bleeding and inflammation of the stomach caused by painkillers such as diclofenac

noreply@blogger.com (Arthur Livermore) — Tue, 02 Jul 2013 20:34:00 +0000

Moderate doses of THC are able to reduce bleeding and inflammation of the stomach caused by NSAIDs (nonsteroidal anti-inflammatory drugs). This is the result of studies with mice conducted by researchers of the Department of Psychology of West Virginia University in Morgantown, USA. The mice were fasted, administered THC (oral or injected into the belly), and then treated with the NSAID diclofenac, which induces gastric damage.

THC dose-dependently attenuated diclofenac-induced gastric bleeding through both routes of administration. THC was effective at low doses, which did not cause locomotor immobility, analgesia and catalepsy. Authors concluded that “these data indicate that the phytocannabinoid delta-9-THC protects against diclofenac-induced gastric inflammatory tissue damage at doses insufficient to cause common cannabinoid side effects.”

Republican Grover Norquist Speaks Out Against Drug War at SSDP Lobby Day

noreply@blogger.com (Arthur Livermore) — Wed, 26 Jun 2013 00:08:00 +0000

Grover Norquist Speaks Out Against Drug War

Click here to watch the video

The Silver Tour - June, 2013

noreply@blogger.com (Arthur Livermore) — Tue, 25 Jun 2013 21:40:00 +0000

It's good medicine

noreply@blogger.com (Arthur Livermore) — Fri, 14 Jun 2013 23:04:00 +0000

Does Granny Need Ganja?

“Marijuana legalization transcends gender, race, class, geography, and age, so it's encouraging to see people from different backgrounds and generations coming together,” Stacia Cosner, SSDP's 26-year-old Associate Director, says. “Young people and seniors don't share a lot of political views and interests, but this is a unique issue that's no longer on the fringe.”

Support medical cannabis

noreply@blogger.com (Arthur Livermore) — Tue, 11 Jun 2013 23:56:00 +0000

noreply@blogger.com (Arthur Livermore) — Tue, 11 Jun 2013 23:34:00 +0000

Veterans Press Statement -> RE: Senate Bill 281 becomes law:

Who: Veterans For Medical Cannabis Access

www.veteransformedicalcannabis.org

Contact: Sgt. Michael Krawitz USAF Disabled 540-365-2141

What: On 6 June 2013 Gov. John Kitzhaber signed SB-281 into law

Oregon: 10 June 2013
By signing SB-281 into law Governor Kitzhaber, as of 1 Jan 2014, adds PTSD as a qualifying condition to Oregon's well established medical cannabis access laws.

Veterans throughout Oregon and indeed the nation whose eyes have been set on this process express gratitude for the swift and decisive action by Oregon's Legislature and Governor making up for years of agony in the futile attempts to broach the entrenched bureaucracy of the Oregon Department of Human Services whose job it was to add this medical condition to the list of those allowed protection of Oregon's medical cannabis access law.

As retired Lt. Commander Al Byrne said "It's About Time"

An effort that Veterans For Medical Cannabis Access [VMCA] has supported from the beginning, adding PTSD to Oregon's law has been an adventure.

VMCA wants to thank Nurse Ed Glick and Atty. Lee Berger for sticking to it through miserable responses from individuals in positions of authority who should know better. Their requests to Oregon's DHS were not only met with inaction but actual hostility at times despite valiant testimony of disabled United States military Veterans flanked by their respective doctors in absolute majority asking for this addition.

VMCA thanks Todd Dalotto and his constituent Senator Boquist for presenting this request to the state legislature and many thanks to all Veterans, EMS, and Police who spoke to their legislators and presented testimony for this bill as well as those survivors of childhood and/or adult trauma whose testimony helped a unchallenged truth become law. The truth? Cannabis works well for PTSD and those who suffer from this medical condition have real evidence and deserve our respect and compassion.

VMCA thanks Anthony Taylor, Director of Compassionate Oregon and Sam Chapman without whose tireless efforts this bill would have been much slower on the uptake and probably wouldn't have passed this year.

Adding to the growing list of states where cannabis is listed specifically as allowed for treatment of PTSD Oregon joins Delaware, Connecticut and New Mexico as well as Massachusetts and California who, wisely, allows doctors to decide these things as well as Washington and Colorado who, maybe even more wisely have re-legalized all personal use by those over 21.

Considering extreme rates of suicide amongst our disabled Veterans taken together with a host of pharmaceuticals that, in this case, suck and the extraordinarily good results we have seen from Veterans who have been able to integrate cannabis into their PTSD regimens VMCA joins Mr. Byrne in saying "It's about time"!

Science Over Ideology? An open letter to President Obama

noreply@blogger.com (Arthur Livermore) — Fri, 10 May 2013 23:38:00 +0000

Science Over Ideology?
And yet the war on pot continues

MAY 9, 2013 - 1:00AM | BY JIM GREIG

An open letter to President Obama:

I am a disabled American worker who uses state approved marijuana for medical reasons. I am offended that you choose to consider me a criminal.

Mr. President, we all know that you smoked a lot of weed as a youth, and that your cannabis consumption did not prevent you from becoming this nation's elected leader. But what seems to be passing over your head, sir, is that had you been arrested for possession of pot, you most certainly would never have become president of the U.S.

You should know that during your first four years in office, while you dodged and dismissed the marijuana issue, some three-quarters of a million people were arrested each year for possession — about three million marijuana arrests just in your first term. I'm curious how that fact fares when we consider your statement at Northwestern University in 2004 that the “war on drugs has been an utter failure."

Mr. President, I'd really like to understand where you're coming from. With 80 percent of U.S. voters supporting medical marijuana legalization and a slim majority favoring adult use, I have a hard time comprehending your reluctance to act properly.

There is no risk to you — and certainly your fellow Democrats in Congress could stand a boost in their popularity.

Mr. Obama, may I remind you that when you were elected, one of your initial points on how your administration would operate revolved around supporting science rather than ideology. You said "promoting science isn’t just about providing resources — it’s about protecting free and open inquiry. It’s about listening to what our scientists have to say, even when it’s inconvenient — especially when it’s inconvenient.”

Well sir, I'm not sure how to break this to you, because it might be "inconvenient" but there is no scientific legitimacy behind the illegality of cannabis in any of its forms. Surely you must agree that the continued prohibition of industrial hemp is absurd. And to deny patients like myself legitimate access to a non-toxic, non-addictive, grow-it-at-home substance that greatly reduces my consumption of toxic pharmaceuticals, is cruel and capricious.

As our commander-in-chief you should know that today 22 veterans will commit suicide. Tomorrow, 22 more. In this country nearly two dozen veterans take their own lives every day. A lot of them suffer from post traumatic stress disorder (PTSD).

When University of Arizona psychiatrist Dr. Sue Sisley put together a study to find how effective cannabis is as a treatment for combat veterans with PTSD she first had to gain FDA and VA approval. Green-lighted from both agencies, her next step was to gain approval from the National Institutes of Drug Abuse. Since NIDA's mission is to find only the harms of drugs, her application was quickly rejected.

In February I was in Washington, D.C., attending the Americas for Safe Access Unity Conference. While there I had the opportunity to meet Dr. John Schwarz, a physicist best known as one of the "fathers of string theory."

In a November 2012 Huffington Post op-ed, Schwarz, who's wife is a medical marijuana patient, criticized your administration for "ignoring scientists' voices on medical marijuana policy ... and severely restricting their ability to conduct new research."

He went on to say the "acceptance of science has come a long way since Galileo was arrested as a heretic for questioning the order of the universe. Yet today, the federal government ignores scientific facts accepted around the globe — not to mention the will of the American people — to cling to outdated ideological policies and restrict marijuana research. This is hardly the 'free and open scientific inquiry' President Obama touted in 2009."

Please, Mr. President. I would like to believe that you are not a hypocrite — that you believe in both science and the will of the American people. You cannot lose, sir, you can only gain.

In the words of Martin Luther King Jr., “Never, never be afraid to do what's right, especially if the well-being of a person or animal is at stake. Society's punishments are small compared to the wounds we inflict on our soul when we look the other way.”

Original article

Medical Cannabis - Healing with an herbal medicine

noreply@blogger.com (Arthur Livermore) — Sun, 28 Apr 2013 22:08:00 +0000

We are raising funds for a project that will produce educational videos about how marijuana is used in the treatment of various medical conditions. We need to raise at least $20,000 to get this project started. We will produce professional quality videos with medical cannabis experts and patients describing how they use marijuana to treat their condition.

Click here to donate

Thank you for your support!

Rick Doblin reply to Bonner

noreply@blogger.com (Arthur Livermore) — Sun, 03 Feb 2013 00:53:00 +0000

Subject:   Rick Doblin reply to Bonner - LA Times: Ex-DEA Head Bonner claims no studies support mj efficacy and that the DEA/NIDA has never blocked a single study

From: Rick Doblin
Date: February 1, 2013

What follows below is a reply I wrote to Bonner's article in the LA Times. I tried to post it below the article but I'm not sure if my text will actually be posted. There was a word limit and I had to post it in five segments. The posts are moderated which adds another layer of review. You can circulate this however you wish.

Dear Mr. Robert Bonner,

Hello from Rick Doblin, Ph.D., (Public Policy, Kennedy School of Government, Harvard University, with my dissertation on the regulation of the medical uses of psychedelics and marijuana). I'm currently Executive Director of the non-profit research and educational organization, the Multidisciplinary Association for Psychedelic Studies (MAPS, www.maps.org), which I founded in 1986. You may be surprised to learn that for the last 20+ years, I have been inspired by, and frequently quote, your 1992 statement that you mention in your article above in which you encouraged advocates of medical marijuana to conduct more research.

In 1992, you wrote, “Those who insist that marijuana has medical uses would serve society better by promoting or sponsoring more legitimate scientific research, rather than throwing their time, money and rhetoric into lobbying public relations campaigns and perennial litigation."

I have put my full energies for the last 20+ years into trying to conduct FDA-approved medical marijuana drug development research. Unfortunately, my experience, to which I hope you will give some credence, is exactly opposite of the open door to research that you claim exists. MAPS has obtained FDA and IRB approval for three different protocols to which NIDA refused to sell any marijuana, preventing the studies from taking place. In addition, NIDA refused for 7 years to sell MAPS 10 grams (!!) of marijuana for laboratory research investigating the vapors that come out of the Volcano vaporizer, compared to smoke from combusted marijuana.

Furthermore, MAPS has been involved for the last decade in litigation against DEA for refusing to license Prof. Craker, UMass Amherst, to grow marijuana exclusively for use in federally regulated research. In 2007, DEA Administrative Law Judge Bittner recommended, after extensive hearings with witness testimony, that it would be in the public interest for DEA to license Prof. Craker to grow marijuana under contract to MAPS, ending the NIDA monopoly on the supply of marijuana legal for use in FDA-regulated studies. DEA waited for almost two years and then rejected the ALJ recommendation just six days before the inauguration of Pres. Obama.

On May 11, 2012, oral arguments took place before the 1st Circuit Court of Appeals in a lawsuit by Prof. Craker challenging DEA's rationale for rejecting the DEA ALJ recommendation. A ruling is currently pending from the 1st Circuit. From my perspective, DEA's rationale for rejecting the DEA ALJ recommendation is arbitrary and capricious, but of course what matters is what the 1st Circuit will eventually decide.

In your article above, you claimed, “To the contrary, not a single scientifically valid study by a qualified researcher has ever been denied by the DEA or, for that matter, by the National Institute of Drug Abuse.”   The wiggle room in your statement above is the definition of "scientifically valid study". One would think that for a privately funded study being conducted without a penny of government money, with the aim of developing marijuana into an FDA-approved prescription medicine, that the FDA would be the regulatory agency to determine whether the study was "scientifically valid” and that Institutional Review Board (IRB) approval would be sufficient to protect the safety of the human volunteers to the study.

However, in 1999, HHS created a policy (which could be reversed by Pres. Obama at any time without Congressional action) stating that PHS/NIDA reviewers would have to conduct an additional review of protocols from privately-funded sponsors seeking to purchase marijuana from NIDA. This additional PHS/NIDA protocol review process exists only for marijuana, not for research with any other controlled substance. MAPS has been able to make substantial progress with our research exploring the use of MDMA-assisted psychotherapy in subjects with chronic, treatment-resistant PTSD, including a current study in 24 US veterans, firefighters and perhaps even police officers with work-related PTSD.

It is these PHS/NIDA reviewers who have rejected all three of MAPS' FDA and IRB approved medical marijuana drug development protocols, preventing them from taking place. You can claim that the rejection of these protocols was because they were not "scientifically valid".   However, to make that claim, you would be saying that FDA and IRBs have approved studies that are not "scientifically valid", an accusation against the FDA that I doubt you really want to make.

MAPS currently has obtained FDA and IRB approval for a study of marijuana in 50 US veterans with chronic, treatment-resistant PTSD. Dr. Sue Sisley of UArizona is the PI and approval has been obtained from the UArizona IRB as well as the FDA. Research into a potentially beneficial treatment for US veterans is being blocked by PHS/NIDA reviewers who rejected this protocol. These PHS/NIDA reviewers approached the protocol review as if we were asking for a government grant for a basic science study. Instead, we were seeking to purchase marijuana from NIDA for a privately-funded drug development study. The PHS/NIDA reviewers made numerous incorrect and uninformed comments and clearly didn't understand drug development research. One reviewer objected to our outcome measures when we are using the FDA-required measure of PTSD symptoms, the CAPS. If you or any readers want to review our protocol along with the PHS/NIDA reviewers' comments and my annotated response, the documents are posted at: http://www.maps.org/research/mmj/marijuana_for_ptsd_study/

The compete record of Prof. Craker's DEA lawsuit is posted at: http://www.maps.org/research/mmj/dea_timeline/

MAPS will soon be resubmitting our marijuana/PTSD protocol for another round of PHS/NIDA review, even though we think this review should be eliminated from the process. All FDA/IRB and DEA approved protocols should automatically be allowed to purchase marijuana from NIDA.

To summarize, you have been an inspiration to me and have motivated me to devote several decades of my life to seek approval for medical marijuana drug development research. My failure to make progress in overcoming the obstruction of medical marijuana research by DEA/NIDA/PHS provides one of the clearest reasons for state level medical marijuana policy reform.

My conclusion is opposite of yours, when you said, "One can only conclude the marijuana proponents did not go this route because doing so would have shown that cannabis is not an effective and safe medicine."

Rather, one can only conclude that privately-funded medical marijuana drug development research is being aggressively and actively obstructed by DEA/NIDA/PHS because they know it can be scientifically proven that marijuana, smoked or vaporized, is both safe and effective.

The heroes in all of this in my eyes are the FDA. It's not because FDA is pro-medical marijuana, or pro-psychedelic psychotherapy. Rather, FDA is pro science over politics. In other words, FDA are heroes simply for doing their jobs. If only DEA/NIDA/PHS considered the public interest over their increasingly out of touch passion for blocking FDA-regulated medical marijuana drug development research.

I urge you to reread your 1992 statement and join MAPS in asking for the end of the PHS protocol review process and for a new policy in which all FDA/IRB/DEA approved protocols automatically obtain approval to purchase NIDA marijuana. In addition, I sincerely hope you will also support DEA licensing of Prof. Craker. It's time to “serve society better by promoting or sponsoring more legitimate scientific research."

Sincerely,

Rick Doblin, Ph.D.
Executive Director, MAPS
3 Francis Street
Belmont, MA 02478 USA
617-484-8711
www.maps.org

Date: February 1, 2013
Subject: LA Times: Ex-DEA Head Bonner claims no studies support mj efficacy and that the DEA/NIDA has never blocked a single study

http://www.latimes.com/news/opinion/opinion-la/la-ol-dea-marijuana-blowbac-20130201,0,5287678.story
BLOWBACK

The DEA's pot defense [Blowback]
By Robert Bonner
February 1, 2013, 8:23 a.m.

Reacting to a federal appellate court decision upholding the U.S. Drug Enforcement Administration's denial of reclassification of marijuana, The Times states in its Jan. 25 editorial that whether marijuana should be reclassified under federal law to permit its prescription as a medicine should be based on science and an evaluation of the facts, rather than on myths. I fully agree.

And yet the editorial is based on the myth that the DEA has made it "nearly impossible" for researchers to obtain marijuana for such scientific studies. To the contrary, not a single scientifically valid study by a qualified researcher has ever been denied by the DEA or, for that matter, by the National Institute of Drug Abuse. And there is ample government-grown marijuana, specifically for research, available at the marijuana farm run by the University of Mississippi. More surprising, as your editorial points out, is that there is still no scientifically valid study that proves that marijuana is effective, much less safe, as a medicine.

As the DEA administrator 20 years ago, I denied the reclassification of marijuana from a Schedule I controlled drug because there were no valid scientific studies showing that smoking marijuana was an effective medicine.

In my decision, published in the Federal Register, I interpreted federal law and set forth a five-part test that included whether there were valid scientific studies demonstrating that marijuana was safe and effective for treating any medical condition. I noted that at that time there were none of the kind of controlled, double-blind studies that the Food and Drug Administration would require before approving a new drug application, and I clearly spelled out that this would be necessary before marijuana would be reclassified to a lower schedule that would permit its use as a physician-prescribed medicine.

Essentially, I invited those who advocate marijuana use as a medicine to conduct research and then present it to the DEA. I laid out a road map for what they needed to do. If scientifically valid studies demonstrated that marijuana was ‘effective’ and ‘safe’, as the FDA defines those terms, the agency would reclassify marijuana into one of the other schedules. It is amazing that 20 years later there is still no such scientific study establishing that marijuana is effective as a medicine. And yet in the interim, the well-funded marijuana lobby, including the National Assn. for the Reform of Marijuana Laws and others, have spent tens of millions of dollars on convincing voters to pass medical marijuana initiatives based on anecdotes but not science.

The reason the FDA and the DEA have scientific standards is because snake-oil salesmen are able to sell just about anything to sick people without any scientific proof that it has a truly helpful therapeutic effect. If proponents of medical marijuana had invested even a small fragment of their money in scientifically valid studies, we would know one way or the other whether it works.

One can only conclude the marijuana proponents did not go this route because doing so would have shown that cannabis is not an effective and safe medicine. Alternatively, we are left to conclude that their agenda was not about marijuana to help sick people, but rather was getting voters to pass medical marijuana initiatives as a wedge to legalize the drug for “recreational" use.

noreply@blogger.com (Arthur Livermore) — Tue, 09 Oct 2012 20:13:00 +0000

Rick Simpson has been providing people with instructions on how to make Hemp Oil medicines for about 8 years. The results, Rick claims, have been nothing short of amazing. The research, backed by hundreds of other studies done worldwide, have proven that properly made hemp medicine provides relief and cures many diseases, even cancer. Simpson has provided hemp oil to hundreds of people with various medical conditions and the results speak for themselves. Throughout man’s history hemp has always been known as a powerful medicinal plant across the world. We’ll discuss Rick’s story and the use of hemp oil as medicine. He’ll explain how it works and talk about the reasons why the pharmaceutical establishment refuses to acknowledge the powerful effects and benefits of Tetrahydrocannabinol (THC).

Endocannabinoids Emerge Out of the Shadows - Ed Glick

noreply@blogger.com (Arthur Livermore) — Tue, 03 Jul 2012 21:28:00 +0000

The Seventh National Clinical Conference on Cannabis Therapeutics met in Tucson, Arizona on April 26-28, 2012. As is customary with this series of conferences, Patients Out of Time brought together a wide variety of clinical, research and experiential presenters who described the expanding universe of endocannabinoid therapeutics. However, this conference became a benchmark in understanding these complex systems. Where previously, underlying mechanisms of action were vaguely understood, today these biochemical pathways have been described in detail. Where previously, researchers (and patients) knew that cannabinoids dampen down excitatory sensory impulses, today they know how this is accomplished. Additionally, research continues to expand the understanding of anti tumor effects of cannabinoids.

Most of the endogenous (anandamide), or exogenous (herbal cannabis), effects are through neuro modulation at the synapse. (Neuro modulation is the activity of a chemical signal which stimulates or dampens the release of neuro transmitters at the space between two nerve cells.) This complicated process acts like a feedback mechanism to the cells pushing them towards homeostasis- or balance. The reason cannabinoids benefit so many different disease states is precisely because this neuromodulation is occurring as a process of homeostatic re-regulation. Since all mammals have evolved the endocannabinoid signaling system over millions of years, the use of cannabis to selectively activate it is nothing short of a profound medical breakthrough-(which patients have been aware of for generations!)

The ocular neuro protective effects of endocannabinoids are also becoming understood and were described by Professor Melanie Kelly of Dalhousie University in Nova Scotia Canada. When nerve cells (neurons) are degraded or inflamed, local endocannabinoid production is increased in that location. Blocking CB1 or CB2 receptor activity increases the susceptibility of that neuron to stroke and trauma. Cannabinoids display neuro protective effects in experimental models of trauma. Again, the activation of cannabinoid receptors (CB1 or CB2) through either endogenous release of anandamide, or through the exogenous use of herbal cannabis, stimulates a return toward homeostasis by decreasing neurological stress and inflammation.

Another researcher, Martin Lee described his research into unlocking the mechanisms of cannabdiol (CBD)- the non-psychoactive cannabinoid. Most readers understand that THC is the cannabinoid in cannabis that is primarily responsible for the euphoria that is prized by recreational users and that was intentionally bred into most strains. What is much less known are the various important effects of the non-psychoactive CBD. Apart from the obvious benefit to some -that it stimulates endocannabinoid signaling without the person getting high -CBD also reduces breast and glioblastoma cell proliferation, may protect neurons against cellular degradation, promotes stem cell neurogenesis (growth), exerts anti psychotic influences, suppresses cardiac arrhythmia, is anti biotic, and has anti-oxidant properties. Interestingly, CBD has little affinity for the cannabinoid receptors, rather it works by activating non cannabinoid receptors and "enhances endocannabinoid tone by inhibiting FAAH ... a key endocannabinoid metabolizing enzyme." FAAH breaks down endocannabinoids, CBD slows the degradation and enhances cannabinoid signaling. (Since it's therapeutic re-discovery in 2009, CBD-rich strains like Cannatonic and Harlequin are being grown specifically for patients who want pain control with less psycho activity.)

In addition to numerous speakers, the Seventh National Clinical Conference on Cannabis Therapeutics was the site for a meeting of the American Cannabis Nurses Association. Founded two years ago, the ACNA is the professional organization for nurses and others who are interested in the unique interaction of nurses and cannabis patients. Nurses all over the country are caring for and in contact with cannabis patients and have little understanding or awareness of its mechanism of action or of the many complex legal issues presented by the Federal governments ongoing war on cannabis patients. How should a nurse counsel a patient about safe use of cannabis? Nursing as a specialty is concerned with the provision of direct patient care, and the subspecialty of cannabis nursing lends itself to this role.

The conference was also attended by a number of physicians, some of whom participated in the first credentialing seminar hosted by the American Academy of Cannabinoid Medicine. This seminar provided physicians with advanced practice certification.

The conference and the venue were enhanced by the sponsorship of the Arizona Center for Integrative Medicine in Tucson. Dr Andrew Weil, author of From Chocolate to Morphine spoke to the gathering exhorting participants to take control of this issue, rather than let it be continually framed by drug war proponents and conservative media. He described the huge education gap of clinicians and the "deep-rooted irrationality" surrounding cannabis. His talk ranged over the limitations of conventional pharmaceutical treatments, contrasting the risk/benefit relationship of cannabis.

The Seventh National Clinical Conference on Cannabis Therapeutics was well attended by over 250 participants, and was held at Loews Ventana Canyon Resort, in the canyons north of Tucson. This spectacular setting was matched by the culinary offerings created by the Loews Chef, who offered many dishes created with hemp.

The field of cannabinoid research has been hampered for decades by overreliance on the single-molecule profit-based health care industry of America. As Dr. Weil pointed out, this accounts for much of the obstruction, insanity, and senselessness of the continuing federal prohibition on cannabis. The very fact that millions of patients can "dispense" with their muscle relaxants, opiates, sedatives and tranquilizers by using a safe and powerful remedy must make pharmaceutical industry accountants break into a cold sweat. Nevertheless, as this conference showed, the re-integration of cannabis into the Pharmacopoeia is now inevitable, and the legal prohibitions are destined to fall like dead leaves on a tree.

The Seventh National Clinical Conference on Cannabis Therapeutics marked, for the first time, the emergence of cannabinoid science from a poorly understood complex process into an increasingly cohesive body of clinical and experiential wisdom which represents the last new frontier of conventional medical advancement. This is, of course, something millions of patients have known for centuries. Their cumulative experience has precipitated this beginning revolution in medical care. Patients are, after all, the leaders here.

Patients Out Of Time (www.medicalcannabis.com)

American Cannabis Nurses Association (www.cannabisnurse.org)

American Academy of Cannabinoid Medicine (www.aacmsite.org)

Arizona Center for Integrative Medicine (www.Integrativemedicine.arizona.edu)

Medical Cannabis educational video project

noreply@blogger.com (Arthur Livermore) — Sun, 22 Jan 2012 01:05:00 +0000

Click here to donate

Education is needed

I am Arthur Livermore and I have been working to educate people about the medical uses of marijuana for more than 30 years. This campaign will produce educational videos about how marijuana is used in the treatment of various medical conditions.

The Impact

Many people have heard that marijuana can be good medicine, but they don't know what is is useful for. These educational videos will be professional quality with medical cannabis experts and patients describing how they use marijuana to treat their condition.

What We Need & What You Get

We need to raise at least $20,000 to get this project started. We will have to invest in video production equipment and pay for travel expenses to interview medical cannabis experts and patients. As a contributor of $1000 to this campaign, you will receive a copy of the finished educational video about the medical condition of your choice.

Other Ways You Can Help

In addition to helping us with your contribution, we would like you to reach out to people who don't understand that marijuana is medicine. Please share this campaign with your friends on Facebook, Twitter, Linkedin, etc. and your local community members.

Click here to donate

Cannabis smoking does not impair lung function

noreply@blogger.com (Arthur Livermore) — Tue, 17 Jan 2012 21:45:00 +0000

Science: Cannabis smoking does not impair lung function according

large long-term study

Cannabis does not impair lung function - at least not in the doses

inhaled by the majority of users, according to the largest and

longest study ever to consider the issue, which was published in the

Journal of the American Medical Association. US researchers conducted

a longitudinal study collecting repeated measurements of pulmonary

function and smoking over 20 years from 1985 to 2006 in 5115 men and

women. "Occasional and low cumulative marijuana use was not

associated with adverse effects on pulmonary function," authors

summarized the results. Lifetime exposure to cannabis cigarettes was

expressed in joint-years, with 1 joint-year of exposure equivalent to

smoking 365 joints (cannabis cigarettes) or filled pipe bowls.

Researchers found that measures of lung function - forced expiratory

volume in the first second of expiration and forced vital capacity -

actually improved slightly as young people reported using more

cannabis - at least up to 7 joint-years or 2,555 joints. "There's no

doubt marijuana triggers a cough," said Dr. Stefan Kertesz, from the

University of Alabama at Birmingham, who worked on the new study. But

questions have remained about the drug's longer-term effect on lung

functioning. Not surprisingly tobacco use was associated with

decreased lung function. But at least at moderate levels of cannabis

smoking, that didn't seem to be the case - in fact, the trend was

reversed. Lung volume and air flow rates both increased with each

joint-year in moderate users. "It's a very real increase (...) but

it's so small that I don't think that a person would feel a benefit

in terms of their breathing," Kertesz said. At the highest levels of

cannabis smoking lung function seemed to decline again, but the

researchers noted that there weren't enough heavy cannabis users in

their study population to be sure of that.

It is unlikely that cannabis puts users at risk of chronic

obstructive pulmonary disease, or COPD, as smoking tobacco does, says

Dr. Donald Tashkin, professor at the University of California in Los

Angeles, who studies the effects of cannabis on the lungs for decades

but wasn't involved in the new study. When it comes to diminished

lung function, "This particular potential complication of marijuana

smoking doesn't appear to be an important risk," he told the press

agency Reuters. "Therefore, people who are using marijuana for

medicinal purposes or recreationally at least could be reassured that

they're not harming their lungs in this way."

More at:

In English

- http://www.reuters.com/article/2012/01/11/us-pot-health-idUSTRE8092BC20120111

- http://healthland.time.com/2012/01/10/study-smoking-marijuana-not-linked-with-lung-damage/#ixzz1jLnFDX5J

In Spanish

- http://www.nlm.nih.gov/medlineplus/spanish/news/fullstory_120727.html

- http://www.jornada.unam.mx/ultimas/2012/01/11/111624097-consumo-ocasional-de-marihuana-no-afecta-los-pulmones-estudio

In German

- http://www.aerzteblatt.de/nachrichten/48717

- http://www.welt.de/gesundheit/article13811166/Kiffen-ist-besser-fuer-die-Lunge-als-Rauchen.html

(Source: Pletcher MJ, Vittinghoff E, Kalhan R, Richman J, Safford M,

Sidney S, Lin F, Kertesz S. Association between marijuana exposure

and pulmonary function over 20 years. JAMA 2012;307(2):173-81.)

Medical Marijuana: The Patient's View

noreply@blogger.com (Arthur Livermore) — Thu, 01 Dec 2011 20:58:00 +0000

On Nov 23, Rafael Lemaitre, Associate Director for Public Affairs of the Office of National Drug Control Policy (ONDCP), stated that "the Food and Drug Administration has not found smoked marijuana to be either safe or effective medicine for any condition". Medical Marijuana: The Government's View

The FDA does not need to determine the medical efficacy of herbal marijuana. Hundreds of thousands of patients have used and are using the marijuana plant to safely treat their illness. Federal marijuana policy is clearly political. Keeping marijuana illegal under federal law is not helping anyone. Removing marijuana from the federal prohibited substances list is the solution.

Why are we wasting precious federal resources trying to subvert state laws? Patients in 16 states and the District of Columbia can use marijuana without breaking state law. It's time to change federal law.

Ideology has driven marijuana policy for decades. The ONDCP claim that public health and safety are protected by marijuana prohibition is an insult not only to patients; it is an insult to all Americans.

Arthur Livermore, National Director
American Alliance for Medical Cannabis